Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Retrospective Cohort Study to Examine the Risk of Serious Infections in Rheumatoid Arthritis Patients Receiving Tocilizumab Compared With Tumor Necrosis Factor Inhibitors Using the National Health Insurance Database

NCT04115423 is registered in ClinicalTrials.gov with Sungkyunkwan University as lead sponsor.

NCT NCT04115423
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04115423 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Retrospective Cohort Study to Examine the Risk of Serious Infections in Rheumatoid Arthritis Patients Receiving Tocilizumab Compared With Tumor Necrosis Factor Inhibitors Using the National Health Insurance Database
Lead sponsor
Sungkyunkwan University
Phase
Observational
Overall status
Unknown status
Start date
April 1, 2020
Completion date
October 1, 2021
Enrollment
9,508 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

infection, rheumatoid arthritis